<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04931264</url>
  </required_header>
  <id_info>
    <org_study_id>YUWELL-YLQX202101</org_study_id>
    <nct_id>NCT04931264</nct_id>
  </id_info>
  <brief_title>Clinical Trial of YuWell YE660D Blood Pressure Monitor in General Population According to the ISO 81060-2:2018</brief_title>
  <official_title>Validation of the YuWell YE660D Oscillometric Upper-arm Blood Pressure Monitor for Clinic and Home in General Population According to the AAMI/ESH/ISO Universal Standard (ISO 81060-2:2018)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Second Hospital of Nanjing Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Jiangsu Yuyue medical equipment &amp; supply Co., Ltd.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The Second Hospital of Nanjing Medical University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the accuracy of the YuWell YE660D oscillometric&#xD;
      upper-arm blood pressure monitor for clinic and home in general population according to the&#xD;
      Association for the Advancement of Medical Instrumentation/European Society of&#xD;
      Hypertension/International Organization for Standardization (AAMI/ESH/ISO) Universal Standard&#xD;
      (ISO 81060-2:2018).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2021</start_date>
  <completion_date type="Anticipated">December 28, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 28, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood pressure measurement data</measure>
    <time_frame>30 minutes</time_frame>
    <description>Systolic Pressure and Diastolic Pressure</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">85</enrollment>
  <condition>Blood Pressure</condition>
  <arm_group>
    <arm_group_label>YuWell YE660D and mercury sphygmomanometer</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Blood Pressure Measurement with the YuWell YE660D Electronic Sphygmomanometer (YuWell YE660D) and with Desk Mercury Sphygmomanometer.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>YuWell YE660D Electronic Sphygmomanometer</intervention_name>
    <description>Measurement blood pressure by YuWell YE660D Electronic Sphygmomanometer and Desk Mercury Sphygmomanometer</description>
    <arm_group_label>YuWell YE660D and mercury sphygmomanometer</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  12 Years and older;&#xD;
&#xD;
          -  Subjects voluntarily participate in the clinical trial and sign the informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Disturbance of consciousness;&#xD;
&#xD;
          -  Patients requiring hemodialysis;&#xD;
&#xD;
          -  Taking anticoagulant drugs due to cardiovascular and cerebrovascular diseases;&#xD;
&#xD;
          -  Pregnant and lactating women;&#xD;
&#xD;
          -  Patients with cardiac arrhythmias;&#xD;
&#xD;
          -  Other conditions that the investigator considers ineligible for clinical trial.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mingzhi Long, MD，PHD</last_name>
    <role>Study Director</role>
    <affiliation>The Second Hospital of Nanjing Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Huijie Zhang, MD，PHD</last_name>
    <phone>86-25-58509670</phone>
    <email>zhanghuijie@njmu.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>The Second Affiliated Hospital of Nanjing Medical University</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210011</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Huijie Zhang, MD PHD</last_name>
      <phone>86-25-58509670</phone>
      <email>zhanghuijie@njmu.edu.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>June 12, 2021</study_first_submitted>
  <study_first_submitted_qc>June 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 18, 2021</study_first_posted>
  <last_update_submitted>September 1, 2021</last_update_submitted>
  <last_update_submitted_qc>September 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Second Hospital of Nanjing Medical University</investigator_affiliation>
    <investigator_full_name>zhang Hui Jie</investigator_full_name>
    <investigator_title>Director of Clinical Trial Center</investigator_title>
  </responsible_party>
  <keyword>blood pressure monitor</keyword>
  <keyword>blood pressure measurement</keyword>
  <keyword>validation study</keyword>
  <keyword>AAMI/ESH/ISO Universal Standard</keyword>
  <keyword>ISO 81060-2:2018</keyword>
  <keyword>YuWell YE660D</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

